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Abstract
Originally developed to regulate neuronal excitability, optogenetics is increasingly also used to control other cellular
processes with unprecedented spatiotemporal resolution. Optogenetic modulation of all major G-protein signalling
pathways (Gq, Gi and Gs) has been achieved using variants of mammalian rod opsin. We show here that the light response
driven by such rod opsin-based tools dissipates under repeated exposure, consistent with the known bleaching
characteristics of this photopigment. We continue to show that replacing rod opsin with a bleach resistant opsin from
Carybdea rastonii, the box jellyfish, (JellyOp) overcomes this limitation. Visible light induced high amplitude, reversible, and
reproducible increases in cAMP in mammalian cells expressing JellyOp. While single flashes produced a brief cAMP spike,
repeated stimulation could sustain elevated levels for 10s of minutes. JellyOp was more photosensitive than currently
available optogenetic tools, responding to white light at irradiances $1 mW/cm
2. We conclude that JellyOp is a promising
new tool for mimicking the activity of Gs-coupled G protein coupled receptors with fine spatiotemporal resolution.
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Introduction
G protein coupled receptors (GPCRs) are the largest family of
metazoan cell surface receptors and contribute to inter- and intra-
cellular communication in all major body systems. They are also
important therapeutic targets, with as many as a third of top-
selling pharmaceutical drugs regulating their activity[1]. Improved
tools to regulate GPCR activity are thus of great interest from both
experimental and therapeutic perspectives.
Optogenetics is one of the most exciting recent technological
developments in neuroscience. In brief, cell types of interest are
engineered to express light-sensitive proteins (photopigments),
allowing light to be used to regulate their activity remotely and
with unprecedented spatial and temporal precision. The most
widely used photopigments in optogenetics are microbial light-
gated ion channels, which have been extensively exploited to allow
direct control of neuronal membrane potential (e.g. [2,3,4] for
reviews). More recently, attention has turned to non-excitable
cells, and to photopigments capable of regulating cellular systems
other than ionic permeability.
The opsin photopigments that support vision across the animal
kingdom are GPCRs whose signalling activity is regulated by light.
They thus represent natural candidates for optogenetic control of
G-protein signalling. Drosophila Rh1 and, more recently, mamma-
lian melanopsin have been used to provide photic control of Gaq
signalling [5,6]. However, the most flexible tools in this area have
been based upon rod opsin, the photopigment of vertebrate rods.
Rod opsin’s cognate G-protein is transducin, a member of the Gai
subclass, and it has been exploited to regulate Gai signalling for
experimental purposes [7,8]. However, thanks to the extensive
structural information available for this protein, chimeric receptors
(recently termed OptoXRs) comprising the light sensitive elements
of rod opsin fused to intracellular signalling components of other
GPCRs have been used to gain access also to the third major class
of G protein, Gas [9,10].
Rod opsin has many advantages as a starting point for designing
optogenetic tools: 1.) It expresses efficiently in non-native en-
vironments without adding specialist chaperones/folding factors.
2.) Its signalling characteristics are well described and specific
[11,12]. 3.) Its basic structure is well-defined, as are many
structure:function relationships [13,14,15,16], facilitating the
design of chimera and site-directed mutants aimed at optimising
its use for particular cell types and modifying its signalling activity.
However, it has one potentially important limitation - its reliance
upon cis-isoforms of retinaldehyde to recover from bleach. In the
vertebrate retina an enzymatic pathway ensures a steady supply of
such cis-isoforms, but this pathway is absent elsewhere in the
mammalian body. It seems likely then that the availability of cis-
retinaldehyde would limit the magnitude of rod-opsin driven
responses outside of the eye. Moreover, while application of
exogenous cis-isoforms could alleviate this problem, the effect of
such an approach should steadily decrease during light exposure as
cis-isoforms are degraded. Previous analyses of OptoXRs have not
probed this behaviour because they have relied upon either end-
point assays of second messenger or single stimulation protocols
[7,10]. Here, using a real time reporter for cAMP, we present
evidence that pigment bleach does indeed impose a fundamental
limit on the magnitude and reproducibility of rod opsin-based
OptoXR activity.
Many opsins from invertebrates (and a very few from
vertebrates) do not bleach like rod opsin. These so-called bistable
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30774pigments bind both cis- and trans- isoforms of retinaldehyde, with
light driving isomerisation in both directions. This comprises an
intrinsic bleach recovery mechanism that makes bistable pigments
much less reliant upon a supply of cis-retinaldehydes. Such bistable
pigments could therefore provide improved tools for optogenetic
control, allowing higher amplitude and more reproducible light
responses. Here we show that a bleach-resistant opsin from the
box jellyfish, Carybdea rastonii, previously shown to be naturally
Gas-coupled [17], does indeed allow much superior control of G
protein signalling. The light dependent increase in cAMP induced
by this ‘JellyOp’ is both higher amplitude and, especially, more
repeatable than the response driven by currently available
OptoXRs. As we also show that JellyOp responds to modest
levels of visible light it represents an accessible tool for optogenetic
control of GPCR signalling.
Methods
Construction of receptors
Construction of chimeric receptors was carried out following
the optimal cytoplasmic boundaries described by Kim et al
(2005)[9]. Our version of the ‘standard’ receptor [9,10] was
designed from human rhodopsin and b2AR sequences (Gen-
bank NM_000539.3 and NM_000024, respectively; Figure 1) to
maximise any future therapeutic potential of the protein. The
sequence also included silent substitutions to introduce unique
restriction enzyme recognition sites within each transmembrane
region to facilitate cloning different cytoplasmic loops. The
nucleotide sequence for Rh1b2AR 1-t with silent substitutions
was synthesised by GenscriptC o r pa n ds u p p l i e di np u c 5 7
cloning vector. A phosphorylation mutant (Rh1b2AR 1-t phos
mutant) was engineered by exchanging serine residues (7 in
total; 261, 262, 345, 346, 355, 356, 364 based on the numbering
of residues of the human b2AR) known to be important for PKA
and GRK phosphorylation for alanine (following [18]), using
site directed mutagenesis (lightning quikchange kit; Stratagene).
In addition, a mutant was created from the standard Rh1b2AR
1-t (termed Rh1b2AR 1-t::Gas) with the stop codon replaced
with a 6-base linker and the coding region for a ‘short’ transcript
of the human Gas protein (Figure 1). The transcript on which
the coding region for Gas was based (GNASS; Genbank
NM_080426.2) has been shown to have less constitutive activity
than longer forms [19]. A 1D4 epitope was fused at the 39 end of
every receptor construct coding region, composed of the last 9
amino acid codons from bovine rhodopsin followed by a stop
codon. All sequences were verified via standard sequencing
techniques prior to use. The coding regions of the receptors
used were flanked by HindIII and NotI sequences and cloned
into the mammalian expression vector pcDNA3.1. The
sequence for the opsin of the box jellyfish Carybdea rastonii
(Genbank AB435549; JellyOp) was also synthesised by Gen-
script Corp in a puc57 vector and fused with a 1D4 epitope. An
HpaI recognition site was introduced into the multiple cloning
site of the pcDNA3.1 vector and the jellyfish sequence flanked
with HpaI and NotI sites for cloning into pcDNA3.1-HpaI. A
jellyfish lysine mutant plasmid was also engineered using site
directed mutagenesis to alter thep u t a t i v ec h r o m o p h o r eb i n d i n g
site at residue 296 from lysine to alanine (numbering from
bovine rhodopsin [14]).
cAMP reporter
A HEK293 cell line expressing the Glosensor
TM cAMP
biosensor under a tetracycline inducible promoter (FLP-IN
TM
system, Invitrogen; Glosensor, Promega; [20]) was generated. This
biosensor is a modified luciferase that carries the cAMP binding B
domain from the RIIb subunit of cAMP-dependent protein kinase
A (PKA). The Glosensor
TM region was excised from the
pGlosensor plasmid (Promega) and cloned into pcDNA5/FRT/
TO, then co-transfected with pOG44 into FLP-IN
TM-293 cells.
Isogenic stable cell lines were selected and maintained with
100 mg/ml hygromycin and 10 mg/ml blasticidin. Cells were
maintained at 37uC in Dulbecco’s modified Eagle’s medium
(DMEM), 4,500 mg/ml D-glucose, sodium pyruvate and L-
glutamine (Sigma) with 10% foetal bovine serum (Sigma) in a
5% CO2 atmosphere. Following incubation with 300 ng/ml
tetracycline, these cells showed repeatable and robust increases
in raw luminescence (RLU) when stimulated with a range of
forskolin concentrations (Figure 2).
The reporter was validated by determining the effect of known
doses of forskolin on levels of cAMP, determined by ELISA and
Glosensor bioluminescence, without any addition of phosphodies-
terase inhibitors. Dose response curves of forskolin could be fit by
both methods by sigmoidal dose response curves of the form y=a
+ b/1+10
(c-x) where a=bottom, b=top-bottom and c= Lo-
gEC50, and yield EC50 values of 51 and 21 mM for ELISA and
luminescence assays respectively, confirming the sensitivity of the
bioassay. The relationship between cAMP and Glosensor response
could then be inferred and fit by a first order polynomial (R
2 value
of 0.999), suggesting that, under these conditions, cAMP
concentration can therefore be estimated from RLU as follows:
[cAMP] mM =4.785 + (0.0003971a) + (0.000005261aˆ2)
where a = RLU/ml.
Light response assays
7.5 x 10
3 FLP-IN
TM-293 Glosensor cells in each well of solid
white 96 well plates were transfected with plasmids containing
opsin based receptors using Lipofectamine 2000 (Invitrogen) in
serum-free medium for 6 hours. Immunocytochemistry revealed
a transfection efficiency of ,50% using this method. A stable
cell line was constructed using a linearised plasmid of pcDNA3-
HpaI JellyOp and additionally maintained with 400 mg/ml
G418. Following transfection (or plating for the stable line), cells
were then incubated for 16 hours with 300 ng/ml tetracycline
and 10 mM retinaldehyde (9-cis retinal or all-trans retinal;
Sigma-Aldrich) in CO2 independent medium without phenol
red (L-15, Invitrogen), with 10% FCS. Beetle luciferin
potassium salt (Promega) reconstituted in 10mM HEPES buffer
was added to a final concentration of 2mM luciferin. All
procedures following transfection of cells with opsins were
carried out in dim red light.
Raw luminescence units (RLU) in cells were recorded at 37uC
with 1s resolution with a top-read 3mm lens in a Fluostar Optima
plate reader (BMG Labtech), with cycles of either 30s or 60s and
gain of 3600. Following 30 mins equilibration, cells were subjected
to repeated flashes from an electronic camera flash (The Jessop
Group Ltd, UK; or forskolin application for cAMP biosensor
validation) followed by recovery periods where RLU was
recorded. Luminescence recordings were analysed with Optima
(BMG Labtech) software and Microsoft Office Xcel. All
experiments comprised cells plated and treated in triplicate. The
average triplicate value for the five minutes prior to light treatment
was used to normalise individual well values of the triplicate that
were then averaged, except where baseline levels were examined.
In the latter case, individual values were normalised to the
triplicate average baseline RLU readings for mock transfected
cells. Prism (Graphpad) software was used for all statistical
analyses.
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TM-293
Glosensor JellyOp cells
7.5610
4 FLP-IN
TM-293 Glosensor JellyOp cells in each well of
solid white 96 well plates were incubated with tetracycline and
retinaldehyde as for temporal responses resulting from transient
transfections above. In addition, for one experiment, 4 x 10
4 FLP-
IN
TM-293 Glosensor JellyOp cells were plated per well following
pre-coating the wells with 0.01% poly-L-lysine (Sigma-Aldrich) in
PBS for 2 hours. Cells were incubated as before and then treated
with vehicle or 100 mM MDL2330A (Tocris Bioscience) for 15
mins before luminescence recordings as above.
An irradiance response curve was created for stable JellyOp
expressing cells as follows. Cells were exposed to 10s of light from
an array of white LEDs (Low energy floodlight, Palmer Riley
Electricals UK) covered with layers of neutral density filter (Lee
Filters, UK). Cells were left to recover and luminescence measured
for 15 minutes and then exposed to a further light pulse brighter
by 1 log unit, and this was repeated up to an irradiance of
4.66 mW cm
22. Spectral irradiance was measured with a
spectroradiometer (Bentham Scientific).
Immunocytochemistry
3.5 x 10
5 cells/ml FLP-IN Glosensor cells were seeded onto
coverslips and transfected with receptor constructs as above. 3.5 x
10
5 cells/ml FLP-IN Glosensor JellyOp cells were seeded onto
coverslips in red light. Following transfections, cells for MAPK
Figure 2. Validating the cAMP biosensor. A HEK293 cell line expressing the Glosensor
TM cAMP biosensor under a tetracycline inducible
promoter (FLP-IN
TM system; Invitrogen) was generated. The reporter was validated by determining the effect of known doses of forskolin on levels of
cAMP, determined by ELISA (a) and Glosensor bioluminescence (b). Data show mean for 2 (ELISA) and 3 (luminescence) separate experiments each of
which contained samples in triplicate. Fits show sigmoidal dose response curves of the form y=a + b/1+10
(c-x) where a=bottom, b=top-bottom and
c= LogEC50, and yield EC50 values of 51 and 21 mM for ELISA and luminescence assays respectively. (c) A comparison of cAMP concentration and
RLU for each forskolin concentration was used to infer the relationship between these parameters. This could be fit by a first order polynomial (R
2
value of 0.999), suggesting that, under these conditions, cAMP concentration can therefore be estimated from RLU as follows: [cAMP] mM =4.785 +
(0.0003971a) + (0.000005261a ˆ2) where a = RLU/ml.
doi:10.1371/journal.pone.0030774.g002
Figure 1. OptoXR sequence alignment. A number of structural variants on a published OptoXR chimera comprising elements of the human
b2AR and human rhodopsin sequences were generated in an attempt to increase response amplitude/reproducibility. An amino acid alignment of
these variants and, for comparison the human b2AR and rhodopsin (Genbank NM_000539.3, in red and NM_000024, in black), and JellyOp (Genbank
AB435549, in blue) sequences are shown. Structural boundaries are based on bovine rhodopsin [14] with putative cytoplasmic regions shaded in dark
grey. The lysine residue in TM7, which forms a Schiff-base linkage with retinaldehyde chromophore, is highlighted in green. Note that the terminal 9
amino acids of rod opsin are included as an epitope tag (1D4) in all receptors used in this study (light grey shading). In addition to the published
OptoXR in which the entire cytoplasmic surface of rod opsin is replaced by that of the b2AR (Rh1B2AR 1-t), variants in which either 1
st or 1
st and 2
nd
intracellular loops from rod opsin were retained (Rh1B2AR 2-t and Rh1B2AR C3,t) in the hope of improving chimera stability were generated. Other
variants on Rh1B2AR 1-t employed site directed mutagenesis of phosphorylation sites (highlighted in red) important for arrestin binding and receptor
inactivation [18] (Rh1B2AR 1-t phos mutant) or a fusion of the human Gas subunit at the C-terminal tail in purple (Rh1B2AR 1-t::Gas).
doi:10.1371/journal.pone.0030774.g001
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mediumwith0.5% FCS and no phenol red. Cellswere incubated with
100 ng/ml pertussis toxin (PTX, Tocris) for 16 hours, 10 mM
U73122 (Tocris) for 30 mins, 100 mM MDL2330A for 15 mins or
L-15 only. Dark treated cells were then washed with ice cold PBS and
f i x e dw i t hi c e - c o l d4 %p a r a f o r m a l d e h y d e( P F A )f o r3 0m i n s .
Simultaneously, light-treated plates were subject to 2 or 15 minutes
exposure to a white LEDarray (The Litebook Company Ltd,Canada,
2.6 mW cm
22at the level of the cells) and fixed as above. For labelling
of the 1D4 epitope, cells were incubated for 16 hours with 9-cis retinal
in L-15 medium with 10% FCS and fixed in the dark.
Fixed cells were blocked and permeabilised with 0.1% Triton-X
100, 5% BSA, 2% normal goat serum in PBS. Phospho-p44/42
MAPK antibody (CST; #9101) was used at a concentration of
1:500 and rhodopsin 1D4 monoclonal antibody (Thermo
Scientific Pearce) at 1:1000. Phospho-MAPK labelled cells were
incubated with a biotinylated secondary antibody and ABC
streptavidin (Vectalabs) complex and developed with a DAB/
Nickel chloride kit (Vectalabs). 1D4 labelling was visualised with
Alexa555-conjugated secondary anti-mouse IgG antibody (Molec-
ular Probes) at 1:1000 and cells were mounted with Vectashield
with DAPI (Vectalabs). Brightfield images of MAPK labelling were
taken with an Axioskop upright microscope with Axiovision CCD
camera and software. Fluorescent images were taken on a Nikon
Eclipse upright 90i confocal microscope using 405nm and 543nm
laser lines.
Results
OptoXR-driven responses have poor reproducibility
Measuring light-dependent cAMP accumulation in optogenetic
studies presents a technological challenge. Standard end-point
assays fail to capture one of the essential features of optogenetics,
the ability for repeated and temporally defined activation.
However, real-time assays based upon fluorescent calcium
reporters or FRET reporters, which are now in standard use to
measure cAMP [21,22,23,24], are inappropriate because the
excitation light for the fluorescence reporter will likely also activate
the optogenetic photopigment. Here, we hoped to avoid these
limitations by using a luciferase-based cAMP reporter, to provide a
live-cell readout of this second messenger without impacting
receptor activity (Figure 2, Figure, 3, Figure 4, Figure 5). We
started by transiently transfecting HEK 293 cells carrying this
reporter with a humanised version of a published OptoXR,
comprising the trans-membrane and extracellular elements of rod
opsin fused to the intracellular components of the b2-adrenergic
receptor (termed here Rh1B2AR 1-t; Figure 1). When these cells
had been pre-incubated with 9-cis retinal, a single brief flash of
light induced a rapid and reversible increase in luminescence
(Figure 3). The magnitude of this response was robust. Thus, at its
peak there was a 3.0760.2 (mean 6 SEM) fold increase in
luminescence over background. We estimate a transfection
efficiency of ,50% from immunocytochemistry (see Methods;
Light response assays). Using the formula derived from the
relationship between Glosensor RLU responses to forskolin and
measured cAMP values stimulated by forskolin, the peak cAMP
light response by the Rh1B2AR 1-t receptor if transfection
efficiency is corrected to 100% was ,5.15 mM. This compares to
around 7.27 mM cAMP produced in response to 1 mM forskolin or
18.48 mM cAMP produced in response to 10 mM forskolin in these
cells. Rh1B2AR 1-t expressing cells pre-incubated with all-trans
retinaldehyde did also show a light response (presumably because
the HEK 293 cell line, unlike primary kidney cells, expresses
RPE65 allowing it to generate cis-isoforms of retinaldehyde
[25,26]), but the associated increase in luminescence was much
smaller than in the 9-cis retinaldyehyde condition (Figure 3).
The potentiating effect of exogenous 9-cis retinaldehyde on the
OptoXR light response is consistent with the known dependence
of rod opsin on cis-isoforms of retinaldehyde. On this basis,
however, the effect is predicted not to survive repeated light
exposure. This indeed was the case. We found that the light
response of cells expressing the published Rh1B2AR 1-t rapidly
diminished under these conditions. Thus, the peak response
amplitude to a second brief flash was reduced by about 50%, with
subsequent responses further diminished. Indeed, by the 5
th flash,
responses were very small, indicating that the potentiating effect of
the exogenous cis-retinaldehyde had been largely lost (Figure 3).
We generated a panel of structural variants of the Rh1B2AR
chimera in an attempt to improve the magnitude of the OptoXR
response. We aimed to obtain a reasonable response amplitude
even in the absence of cis-retinaldehdyes and/or under repeated
light exposure (Figure 4). One, in which the first cytoplasmic loop
Figure 3 Real time analysis of a standard OptoXR response. Light induced changes in cAMP biosensor (Glosensor) luminescence in HEK293
cells transiently transfected with Rh1B2AR 1-t. Data for cells incubated with 9 cis retinaldehyde (black) or all trans retinaldehyde (grey) are shown;
yellow arrows depict presentation of light flash. Data points show mean 6 SEM n=7. Inset shows immunocytochemical staining for the 1D4 epitope
(in red, alexa 555 secondary antibody) of HEK293 cells expressing Rh1B2AR 1-t. DAPI shown in blue, scale bar =10 mm.
doi:10.1371/journal.pone.0030774.g003
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improved the initial light response (peak RLU) following pre-
treatment with 9-cis retinaldehyde (one-way ANOVA with
Dunnett’s post hoc comparison to Rh1B2AR 1-t, p,0.01,
figure 4e). However, none of them overcame the fundamental
limitation in response reproducibility.
Improved responses in cells expressing JellyOp
The family of animal opsins contains members who are less
susceptible to bleach than rod opsin, and one of these from the box
jellyfish Carybdea rastonii has recently been shown to couple to Gas
in vitro [17]. We therefore next determined whether this opsin
(termed JellyOp here) would allow us to overcome the poor
Figure 4. Real time analysis of OptoXR variant responses. (a–d) Light induced changes in cAMP biosensor (Glosensor) luminescence in
HEK293 cells transiently transfected with Rh1B2AR 2-t (a) Rh1B2AR 1-t phos mutant (b), Rh1B2AR 1-t::Gas( c) or Rh1B2AR C3,t (d). Luminescence was
measured for 1 second every minute and _ormalized to baseline dark levels. Yellow arrows depict presentation of light flash. (e) Quantification of
peak response amplitude for the first light flash following incubation with 9 cis retinaldehyde reveals that only the Rh1B2AR 2-t chimera shows an
improved response amplitude compared to the Rh1B2AR 1-t OptoXR (one-way ANOVA with Dunnett’s post hoc comparison to Rh1B2AR 1-t p,0.01).
(f) None of these chimera exhibited reduced dark activity (luminescence prior to light exposure, _ormalized to mock transfected control cells), and
indeed this parameter was significantly increased in cells expressing Rh1B2AR 1-t::Gas when preincubated with 9 cis retinaldehyde (one-way ANOVA
with Dunnett’s post hoc comparisons to mock transfections as control group, p,0.05). *p,0.05, **p,0.01. Data show mean 6 SEM (n$4) shown for
cells preincubated overnight with either 9-cis retinaldehyde (black) or all trans retinaldehyde (grey).
doi:10.1371/journal.pone.0030774.g004
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OptoXRs.
When reconstituted overnight with 9-cis retinaldehyde, cells
transiently transfected with JellyOp showed a 5.960.5 fold
increase in cAMP reporter activity following a single light flash
(Figure 5a&b). This is significantly greater than the best response
we achieved with Rh1-based OptoXRs (from Rh1B2AR 2-t;
p,0.05 one tailed t-test). Interestingly, the kinetics of the JellyOp
response were also increased, with a sharper decline in
luminescence suggesting that this receptor may allow finer
temporal control of the second messenger. The real advantage
of using JellyOp was, however, in the response to repeated
stimulation. Thus, JellyOp-driven responses to subsequent flashes
were only modestly reduced, and a series of 5 flashes maintained
cAMP at a much higher level than that obtainable with OptoXRs
(one-way ANOVA with Dunnett’s post-hoc test, p,0.01;
Figure 5d). The implication that JellyOp is able to support high
amplitude cAMP responses without exogenous cis-retinaldehyde
was confirmed by the activity of cells pre-incubated with all-trans
retinal (Figure 5c). In these cells, response amplitude showed no
sign of decreasing under repeated stimulation and, if anything,
increased. Similarly, the JellyOp response under these conditions
was much greater than that of OptoXRs (one-way ANOVA with
Dunnett’s post-hoc test, p,0.001, Figure 5e).
Basal levels of luminescence were modestly increased in cells
expressing JellyOp. Thus, cells preincubated with 9-cis retinalde-
hyde had 1.2160.1 times greater luminescence in the dark than
untransfected controls, and 1.8160.16 times greater luminescence
with all-trans retinaldehyde. This likely represents genuine basal
(dark) activity of the receptor, although given the high photosen-
sitivity of JellyOp (see below), light produced by the luciferase
reporter may also have driven some receptor photoactivation.
JellyOp sensory characteristics
In order to further characterise the sensory characteristics of
JellyOp in HEK293 cells, we generated a cell line stably expressing
this opsin. The first notable feature of this cell line was the
magnitude of light responses. We found that a single brief light
pulse could increase luminescence by 24.4762.22 (n=5) fold in
cells pre-incubated with 9-cis retinaldehyde (approx. 7.63 mM
cAMP). Moreover, we were able to maintain this level of reporter
activity for at least 15 mins with repeated stimulation (Figure 5f).
Consistent with the view that JellyOp-dependent increases in
luminescence reflect opsin-based activation of adenylate cyclase
activity via a Gas cascade, we found that the light response of
these cells was repressed by an adenylyl cyclase inhibitor
(MDL2300A) and absent when a JellyOp mutant lacking the
lysine critical for chromophore binding was used (Figure 5g,h).
Treatment with inhibitors of canonical Gi or Gq cascades
(pertussis toxin, a Gi inhibitor or U73122, a PLC inhibitor),
however, did not have an effect on the light response (data not
shown).
The most commonly used optogenetic tools require very bright
light for activation [10,27,28]. We next determined whether this
was also true for JellyOp by describing the irradiance dependence
of the cAMP response in the stable cell line. We found a
measurable increase in luminescence could be induced by 10s
pulses of white light (LED source) at irradiances $1 mW/cm
2
(Figure 5i). For reference, light levels at bench-top in our
laboratory are typically around 200 mW/cm
2. In fact this likely
overestimates the light required to activate JellyOp because much
of the energy produced by the white LED will be inefficiently
absorbed by the pigment. JellyOp is maximally sensitive to light of
around 500nm in wavelength [17], and we estimate that responses
could be elicited by as little as 11 log photons/cm
2/s (,100 nW/
cm
2) if a 500nm narrow band light source were employed. The
increase in reporter luminescence at these threshold irradiances
corresponds to that induced by around 1 mM forskolin.
Light dependent mitogen activated protein kinase
(MAPK) signalling
GPCR signalling is not restricted to conventional Ga/second
messenger pathways but may also involve Gbc and G-protein
independent (b-arrestin) pathways that can lead to MAPK
phosphorylation and activation of other cascades, typically
following a longer time course than the conventional pathways
[29]. We found that both JellyOp and all of the OptoXRs used in
this study drove a light dependent increase in MAPK phosphor-
ylation in HEK293 cells (Figure 6). Thus, there was a marked
increase in immunoreactivity for phospho-MAPK, following 2 or
15 minutes exposure to a white LED based light source
(Litebook
TM; 2.6 mW cm
22) in HEK293 FLP-IN Glosensor cells
transiently expressing any of these receptors. In agreement with
data from cAMP Glosensor recordings, treatment of cells
expressing JellyOp with inhibitors of canonical Gi or Gq cascades
(pertussis toxin or U73122) did not result in measurable reduction
of MAPK phosphorylation following light treatment. Conversely,
treatment with an adenylate cyclase inhibitor inhibited MAPK
phosphorylation at both shorter and longer (15 mins) time points.
This indicates that MAPK phosphorylation under these conditions
is downstream of an increase in cAMP rather than attributed to G
protein independent pathways following light activation.
Discussion
The conventional approach to manipulating GPCR activity is
pharmaceutical. However, drugs have a number of well-recog-
nised limitations. Off-target effects on tissues and cell types other
Figure 5. JellyOp driven light responses. (a) Light induced changes in cAMP biosensor luminescence (depicted _ormalized to baseline before
light exposure) in HEK293 cells transiently transfected with JellyOp (n=5). (b,c) The peak increase in luminescence following the first light flash was
significantly greater for 9-cis pretreated cells expressing JellyOp than either the Rh1B2AR 1-t (1-t) or Rh1B2AR 2-t (2-t) chimera. It was also significantly
greater for all-trans pretreated cells expressing JellyOp than Rh1B2AR 1-t. (d,e) Sustained responses were further enhanced, with luminescence over
5 minutes of light exposure (flashes once per minute) reaching a plateau significantly higher in JellyOp than either Rh1B2AR chimera. (f) Tracking
changes in luminescence with higher temporal resolution (reading every 30s) in HEK293 cells stably transfected with JellyOp revealed high
magnitude responses that could be sustained over 15 minutes of repeated stimulation (n=4). Inset shows immunocytochemical staining for 1D4
epitope (red) in JellyOp expressing HEK293 cells. Nuclei stained blue with DAPI; scale bar 10 mm. (g) Cells stably expressing JellyOp show markedly
repressed responses to a light flash when treated with 100 mM MDL2330A (adenylate cyclase inhibitor; dashed line), n=1 (h) cAMP biosensor
luminescence responses in HEK293 cells transiently transfected with JellyOp (continuous line) are abolished in the JellyOp lysine mutant (dashed line),
n=1(i) Irradiance response curves for cAMP reporter activity in cells stably expressing JellyOp and induced with 10s white light (LED) pulses. RLU
values are _ormalized to the peak response (n=3). A-I show cells pre-incubated with either 9-cis (black) or all-trans (grey) retinaldehyde; mean 6
SEM; yellow arrows depict timing of light flash. Data in b-e were analysed using one-way ANOVA with Dunnett’s post hoc comparisons to JellyOp as
control group, *p,0.05, **p,0.01; n$4.
doi:10.1371/journal.pone.0030774.g005
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systems, while the kinetics of drug delivery and clearance impose
a limit on the temporal resolution with which systems can be
manipulated. Optogenetics provides an exciting opportunity to
overcome these problems by using a ‘ligand’ (light), which can be
applied with mm/msec spatiotemporal resolution, to activate a
receptor targeted to specific cell types using the tools of genetic
engineering. The ultimate expression of this technology will be to
impose natural patterns of GPCR activity. Realising this
ambition will, however, require optogenetic tools that allow both
repeatable and sustained activation. There is abundant evidence
that this level of control is physiologically relevant. Thus, cAMP
signalling in units as small as sub-cellular compartments has been
described [30,31,32], while pulsatile and oscillatory patterns of
cAMP concentration are common and can elicit different
downstream responses than continuous cAMP elevations
[22,33,34,35]. The data presented here suggests that this is
achievable using JellyOp, a bleach resistant visual opsin from the
box jellyfish Carybdea rastonii.
Optogenetic control of Gas signalling has previously been
achieved using chimeric receptors comprising light absorbing
elements of mammalian rod opsin and G-protein interaction
domains from other GPCRs [9,10]. Such OptoXRs have been
used successfully to regulate cAMP and Ca
2+ in vitro and in vivo,
but the reproducibility and sustainability of activation have not
been rigorously interrogated. Here we first set out to achieve this
using a new luciferase-based cAMP biosensor to track live cell
responses driven by OptoXRs. Our data reveal intrinsic
limitations to the currently available rhodopsin/b2 adrenergic
receptor chimera (Rh1B2AR 1-t). Thus, although light drove a
clear induction of cAMP in HEK293 cells expressing this receptor,
responses were low amplitude without preincubation with cis-
retinaldehyde. We were able to achieve modest improvements in
this aspect of performance by changing chimera design. However,
the more important deficit was in response reproducibility, and
none of our revised OptoXRs were able to recover the precipitous
decline in response amplitude over repeated stimulation. This
aspect of OptoXR behaviour is predicted by the bleaching
characteristics of rod opsin, which requires a ready supply of cis-
retinaldehyde to remain photosensitive in its native environment.
As the enzymatic machinery required to generate large amounts of
cis-retinaldehyde is restricted to the eye in mammals, this could be
an important limitation to optogenetic application. Some
researchers have applied exogenous cis-retinaldehyde when using
rod opsin-based tools for optogenetic control [7]. Our data suggest
that this represents only a partial solution to the problem, as its
effectiveness should rapidly decline under repeated or continuous
light exposure.
Our data suggest that JellyOp overcomes these critical
limitations to allow reproducible and sustained cAMP responses.
These features are consistent with published evidence that
JellyOp is intrinsically bleach-resistant. Many animal opsins
have two photo-interconvertible stable states binding either cis-
or trans-isoforms of retinaldehyde. This enables them to remain
photosensitive under repeated/continuous light exposure. The
photobiology of JellyOp is incompletely understood, but
Koyanagi et al (2008 [17]) were able to show that when
purified JellyOp was reconstituted with 11-cis retinaldehyde,
light exposure led to creation of a thermostable pigment binding
all-trans retinaldehyde and absorbing visible wavelengths. In
order to be fully bleach resistant, further light exposure should
reconstitute the 11-cis isoform. Koyanagi et al (2008 [17]) did
Figure 6. MAPK phosphorylation. Immunohistochemical labelling of phosphorylated MAPK (grey-black stain produced with horseradish
peroxidise and diaminobenzidine) in HEK293 cells preincubated with 9-cis retinaldehyde and exposed to either 2 minutes of white light or kept in the
dark. (a) OptoXRs elicit a light dependent increase in MAPK phosphorylation. Photomicrographs for untransfected cells and cells expressing each of
the OptoXRs were taken with the same exposure settings. Scale bar =50 mm. (b) Phosphorylated MAPK in HEK293 cells expressing JellyOp exposed
to the dark or 15 mins of light. Cells labelled ‘+PTX’ were treated with 100ng/ml pertussis toxin (a Gi inhibitor); ‘+U73122’ with 10 mM U73122 (a Gq
inhibitor); ‘+MDL2330A’ with 100 mM (adenylate cyclase inhibitor). MDL inhibits light-induced MAPK phosphorylation following both 2 mins (not
shown) and 15 mins of light. The increase in phosphorylation therefore appears to be due to a Gs dependent pathway.
doi:10.1371/journal.pone.0030774.g006
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may be due to inadequacies in the in vitro environment. Our
data support that view. The relatively poor performance of our
rod-opsin based OptoXRs except in the presence of exogenous
cis-retinaldehdye highlights how important such bleach-resis-
tance is likely to be for in vivo application. A new generation of
optogenetic tools based upon bleach-resistant animal opsins
could then be contemplated.
JellyOp is the only animal opsin known to be Gas coupled. This
has enabled us to use it to achieve control of Gas signalling
without OptoXR-like modifications of putative G-protein inter-
action domains. Nevertheless, future work could usefully concen-
trate on structural modifications to the receptor. The intracellular
surface of GPCRs is responsible not only for defining G-protein
specificity, but also for targeting the receptor to specific cellular
compartments; defining the rate of receptor deactivation; and
coupling to non-canonical signalling pathways. It should therefore
be possible in future to adjust these aspects of JellyOp activity by
changing its intracellular domains. This potential to approximate
multiple aspects of native GPCR activity sets JellyOp aside from
other approaches directly targeting cAMP production. A group of
microbial photoactivated adenylate cyclases (PACs) have been
used to achieve this latter goal [28,36,37,38], although it is not yet
clear whether these PACs approach the repeatability/sustainabil-
ity of JellyOp signalling.
One most notable feature of JellyOp is its high sensitivity. We
achieved pharmacological levels of cAMP induction with a white
light stimulus as low as 1 mW/cm
2. This is many orders of
magnitude below that required to activate the microbial light
gated ion channels used so widely in neuroscience [27] and at least
10x below the threshold for the most sensitive currently available
optogenetic tools [38,39,40]. As this means that JellyOp can be
activated using simple, inexpensive, white light sources, it makes it
a very accessible technology.
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